SCHEMBL8425448

SCHEMBL8425448

O=C(O)N(Cc1ccccc1)c1ccc(N2CCOCC2)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.56
NPC1 O15118 4/20 0.56
RAB9A P51151 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
TP53 P04637 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
KDM4E B2RXH2 3/20 0.50
CYP1A2 P05177 3/20 0.50
CYP3A4 P08684 3/20 0.50
CYP2C19 P33261 3/20 0.50
CASP1 P29466 1/20 0.50
MAPT P10636 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALDH1A1 P00352 4/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 2/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8427222 0.88 ALDH1A1 (0.48) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL8432299 0.86 HTR6 (0.46) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL483675 0.84 NPC1 (0.51) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL18396730 0.84 KMT2A (0.41) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL3156650 0.83 SMN1; SMN2 (0.54) NPC1RAB9ASMN1; SMN2TSHRCYP2C19
SCHEMBL8425426 0.82 NPC1 (0.50) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL18595786 0.81 HPGD (0.48) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL5789493 0.81 PKM (0.49) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL5791554 0.81 MAOB (0.44) HPGDNPC1RAB9ASMN1; SMN2TP53
SCHEMBL15618875 0.81 NPC1 (0.47) HPGDNPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106316988-A Preparation method of linezolid injection degradation impurity 重庆常捷医药有限公司 2017-01-11 CN disclosed
US-5990309-A 2-chloro-5-fluoro-4-morpholinonitrobenzene and 2-chloro-5-fluoro-4-morpholinoaniline CLARIANT GMBH (DE) 1999-11-23 US disclosed
US-5917037-A Process for the preparation of n-carboxyalkyl-3-fluoro-4-dialkylaminoanilines CLARIANT GMBH (DE) 1999-06-29 US disclosed
US-5917036-A Process for the preparation of N-carboxyalkyl-3-fluoro-4-dialkylaminoanilines CLARIANT GMBH (DE) 1999-06-29 US disclosed